"Humana's Stock Plummets on Bleak 2024 Outlook and Soaring Medical Costs"

Humana's stock plummeted after the company reported a widened quarterly loss due to soaring medical costs and slashed its 2024 profit guidance to nearly half of analysts' expectations. The company cited higher Medicare Advantage costs and slower-than-expected enrollment growth as contributing factors. Despite a bleak outlook, some analysts believe the current trends may not persist throughout the year, potentially setting the stage for improved performance in 2025.